Verified
Evidence: resolved ·
Fact Lock: locked ·
QA: pass
Google DeepMind has reportedly released AlphaGenome 2, a conditional DNA sequence model designed to predict regulatory activity and variant effects for individual cell types, according to MarkTechPost.
MarkTechPost described AlphaGenome 2 as a conditional model that links DNA sequence analysis to cell-type-specific predictions of regulatory activity and genetic variant effects. The report did not provide technical evaluation results or additional details about the model’s performance.
According to the same report, the model is accessible through the AlphaGenome API for non-commercial research. MarkTechPost published its account on November 11, 2026; the supplied evidence does not independently establish that date as the product’s release date.
The release account is based on a single supplied source. No official Google DeepMind announcement or independent corroborating report was included in the available evidence.